KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $405.0 million.

  • Bausch Health Companies' Cash from Operations changed 0.0% to $405.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 865.8%. This contributed to the annual value of $1.6 billion for FY2024, which is 5474.81% up from last year.
  • Bausch Health Companies' Cash from Operations amounted to $405.0 million in Q3 2025, which was down 0.0% from $289.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Cash from Operations registered a high of $601.0 million during Q4 2024, and its lowest value of -$1.3 billion during Q3 2022.
  • For the 5-year period, Bausch Health Companies' Cash from Operations averaged around $222.7 million, with its median value being $289.0 million (2025).
  • Examining YoY changes over the last 5 years, Bausch Health Companies' Cash from Operations showed a top increase of 187916.67% in 2022 and a maximum decrease of 32393.62% in 2022.
  • Over the past 5 years, Bausch Health Companies' Cash from Operations (Quarter) stood at $24.0 million in 2021, then skyrocketed by 1879.17% to $475.0 million in 2022, then decreased by 17.89% to $390.0 million in 2023, then skyrocketed by 54.1% to $601.0 million in 2024, then crashed by 32.61% to $405.0 million in 2025.
  • Its Cash from Operations stands at $405.0 million for Q3 2025, versus $289.0 million for Q2 2025 and $211.0 million for Q1 2025.